A team of researchers at Heriot-Watt University have said they have shown 'extremely encouraging' results in their first ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative, patient-focused treatments, today responded to recent market rumors and inquiries from ...
Zacks Small Cap Research on MSN51m
COCP: Phase 2a Trial of CC-42344 Extended…
COCP READ THE FULL COCP RESEARCH REPORT Business Update Phase 2a Trial of CC-42344 Extended On December 31, 2024, Cocrystal ...
Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent Washington ...
Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...
Topline results from a phase 2/3 clinical trial showed that an eIF2B agonist to treat ALS failed to meet its primary endpoint ...
Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.
Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...
Annual Guidance of $178 - $182 Million in Revenue and $38 - $42 Million of Adjusted EBITDA, Representing Year-Over-Year Increase of 13% in Revenues and 19% in Adjusted EBITDA Based on ...
By integrating Ryght AI's technology with QPS's experience and global network, the collaboration aims to streamline clinical ...